A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Golimumab in the Treatment of Chinese Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy.
Phase of Trial: Phase III
Latest Information Update: 05 Sep 2013
At a glance
- Drugs Golimumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 15 Jun 2013 Results presented at the 14th Annual Congress of the European League Against Rheumatism.
- 09 Aug 2012 Actual end date (Jul 2012) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History